Skip to main content
. 2020 Dec 17;41(3):1127–1145. doi: 10.1161/ATVBAHA.120.315031

Figure 4.

Figure 4.

Extracellular vesicles (EVs) attenuate oxygen glucose deprivation (OGD)-induced upregulation of ABCB1 (ATP-binding cassette subfamily B member 1 transporter) via inhibiting the NF-κB (nuclear factor-κB) pathway. A, Quantitative analysis of p65 expression of cytoplasm and nucleus fractions in normoxia control, OGD, and OGD treated with EVs groups using Western blot analysis normalized with the housekeeping proteins GAPDH in the cytoplasm fractions and Histone H3 in the nucleus fractions. B, Nonquantitative immunofluorescence staining of p65 (green), EVs-DiI (red), and DAPI (blue) in 3 groups showed p65 nuclear translocation of the NF-κB pathway. Scale bars: 20 µm. C and D, Quantitative analysis of ABCB1 and p65 expression by Western blot analysis in normoxia control, OGD, OGD treated with EVs, OGD with SN50 (NF-κB translocation inhibitor) and OGD with valspodar (ABCB1 inhibitor) groups. Western blots were normalized with the housekeeping protein α-tubulin (n=3 per group). E, Statistical analysis of rhodamine 123 accumulation in ECs representing ABCB1 transporter activity were done in the same groups (n=6 per groups). DAPI indicates 4’,6-diamidino-2-phenylindole. Data are expressed as mean±SD, *P<0.05, **P<0.01, ***P<0.001, ****P<0.0001.